Handelsbanken Fonder AB »

Blueprint Medicines shares owned by Handelsbanken Fonder AB

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Handelsbanken Fonder AB from 13F filings

Historical chart of Handelsbanken Fonder AB investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Handelsbanken Fonder AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Handelsbanken Fonder AB

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.2M 13k 92.24
2023-09-30 $660k 13k 50.19
2023-06-30 $831k 13k 63.19
2023-03-31 $668k 15k 44.98
2022-12-31 $449k 10k 43.80
2022-09-30 $629k 9.6k 65.86
2022-06-30 $482k 9.6k 50.47
2022-03-31 $610k 9.6k 63.87
2021-12-31 $1.0M 9.6k 107.11
2021-09-30 $1.2M 12k 102.81
2021-06-30 $1.1M 12k 87.96
2021-03-31 $880k 9.1k 97.23
2020-12-31 $1.0M 9.1k 112.14
2020-09-30 $839k 9.1k 92.70
2020-06-30 $706k 9.1k 78.00
2018-09-30 $1.5M 19k 78.05
2018-06-30 $1.2M 19k 63.47